Daily Earnings

It was a mixed day for earnings, with some significant beats and strong guidance alongside notable misses.

Guidance and Results Summary:

• Micron Technology (MU):
  • Beat Q2 earnings ($12.20 vs $8.81 est) and revenue ($23.86B vs $19.15B est).
  • Q2 revenue grew 196.29% year-over-year.
  • Provided strong Q3 guidance, expecting higher EPS ($18.75-$19.55 vs $12.03 est) and revenue ($32.75B-$34.25B vs $24.21B est).
  • Increased quarterly dividend by 30%.
• Hyperfine (HYPR): Sees 2026 revenue above estimates ($20.0M-$22.0M vs $18.0M est).
• Spire Corp. (SPIR): Guided Q1 and full-year 2026 loss and revenue below consensus estimates.
• XOMA (XOMA): Beat Q4 earnings ($0.12 vs -$0.13 est) and revenue ($13.76M vs $10.38M est).
• Protalix BioTherapeutics (PLX): Missed Q4 earnings (loss of -$0.07 vs $0.01 est) and revenue ($9.12M vs $14.36M est).
• Other Positive Guidance: Five Below (FIVE), One Stop Systems (OSS), Jabil (JBL), Heartflow (HTFL), Usio (USIO).
• Other Negative Guidance: uCloudlink (UCL) (Q1 below), SailPoint (SAIL), Kanzhun (BZ), H World Group (HTHT).
• Upcoming (Next Day): Alibaba Group Holding (BABA) is expected to miss estimates on March 19, 2026.

Top Surprises:

• Micron Technology (MU): Significantly beat both earnings and revenue expectations for Q2, and issued very strong Q3 guidance, suggesting robust demand in the AI era.
• XOMA (XOMA): Reported a substantial earnings beat (192.31% above consensus) and strong revenue growth.
• Protalix BioTherapeutics (PLX): Missed consensus earnings estimates by a large margin (800% miss) and saw a significant revenue decline.
• Spire Corp. (SPIR): Provided guidance for Q1 and full-year 2026 that was notably below analyst expectations for both earnings and revenue.